current page
  • HOME
  • Business Overview

Business Overview

Terumo is Rising to the Challenges to Innovate in Three Business Areas

Terumo contributes to society through healthcare by doing business through three companies.
We provide optimal products and services to medical settings the world over. In pursuing higher quality in medicine, we introduce improvements for greater safety and ease of use, conduct training to promote proper use of devices, and propose systems for comprehensively meeting the needs of medical settings.

Business Sales
Sales by Region

Cardiac & Vascular Company

Realizing minimally invasive treatments through endovascular interventions for various parts of the body and in cardiovascular surgery

Cardiac & Vascular Company

The Cardiac and Vascular Company specializes in two primary therapeutic areas—endovascular intervention and cardiovascular surgery. In endovascular intervention, catheters are inserted to perform diagnosis or treatment. Terumo focuses on coronary, peripheral, aortic, and neurovascular interventions, as well as interventional oncology in the form of chemo-embolization for liver cancer.
In the area of cardiovascular surgery, we develop cardiopulmonary bypass systems, artificial vascular grafts, and other products. Our goal in all of these areas is to lower physical burdens on patients and achieve better therapeutic effectiveness.

General Hospital Company

Through unique technology and services, improving safety and efciency in medical settings, while raising patient quality of life and innovating drug delivery

General Hospital Company

From hospital bedsides to patient homes, increasingly diverse medical settings require medical devices and drugs with functionality and usability that fit each situation. The General Hospital Company systemizes products to treatments and procedures, and provides platforms that link data through IT to raise safety and efficiency while improving patient quality of life.
The company also focuses on developing syringes optimized for biopharmaceuticals, and on a CMO business model using advanced sterilized manufacturing technology; by bringing new value to pharmaceuticals, Terumo contributes to the advancement of drug delivery.

Blood Management Company (Terumo BCT)

The Blood Management Company drives customer value and enhances patient outcomes through blood component, therapeutic apheresis, and cellular technologies

Blood Management Company (Terumo BCT)

As a global leader in blood component, therapeutic apheresis, and cellular technologies, the Blood Management Company (Terumo BCT) is the only company with the unique combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction technologies. We believe in the potential of blood to do even more for patients than it does today. This belief inspires our innovation and strengthens our collaboration with customers.


Return to page top